Activation of Trpv4 Reduces the Hyperproliferative Phenotype of Cystic Cholangiocytes From an Animal Model of ARPKD

Gastroenterology

Volumn 139, Issue 1, 2010, Pages

  Gradilone, Sergio A ^a   Masyuk, Tatyana V ^a   Huang, Bing Q ^a   Banales, Jesus M ^a,b   Lehmann, Guillermo L ^a,c   Radtke, Brynn N ^a   Stroope, Angela ^a   Masyuk, Anatoliy I ^a   Splinter, Patrick L ^a   LaRusso, Nicholas F ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Calcium; Cholangiocytes; PKD; Trpv4

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; VANILLOID RECEPTOR 4;

ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BILE DUCT; CALCIUM CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOGOLD ELECTRON MICROSCOPY; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 77954071076     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.04.010     Document Type: Article

References (55)

1. Everson G.T., Taylor M.R., and Doctor R.B. Polycystic disease of the liver. Hepatology 40 (2004) 774-782
2. Harris P.C., and Torres V.E. Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy. Curr Opin Nephrol Hypertens 15 (2006) 456-463
3. Reynolds D.M., Falk C.T., Li A., et al. Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1. Am J Hum Genet 67 (2000) 1598-1604
4. Li A., Davila S., Furu L., et al. Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease. Am J Hum Genet 72 (2003) 691-703
5. Davila S., Furu L., Gharavi A.G., et al. Mutations in SEC63 cause autosomal dominant polycystic liver disease. Nat Genet 36 (2004) 575-577
6. Shneider B.L., and Magid M.S. Liver disease in autosomal recessive polycystic kidney disease. Pediatr Transplant 9 (2005) 634-639
7. Adeva M., El-Youssef M., Rossetti S., et al. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine (Baltimore) 85 (2006) 1-21
8. Masyuk T.V., Masyuk A.I., Torres V.E., et al. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3′,5′-cyclic monophosphate. Gastroenterology 132 (2007) 1104-1116
9. Calvet J.P., and Grantham J.J. The genetics and physiology of polycystic kidney disease. Semin Nephrol 21 (2001) 107-123
10. Guay-Woodford L.M. Autosomal recessive polycystic kidney disease (ARPKD): new insights from the identification of the ARPKD gene, PKHD1. Pediatr Res 52 (2002) 830-831
11. Zerres K., Mucher G., Becker J., et al. Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 76 (1998) 137-144
12. Masyuk T., and LaRusso N. Polycystic liver disease: new insights into disease pathogenesis. Hepatology 43 (2006) 906-908
13. Onuchic L.F., Furu L., Nagasawa Y., et al. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 70 (2002) 1305-1317
14. Ward C.J., Hogan M.C., Rossetti S., et al. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet 30 (2002) 259-269
15. Yamaguchi T., Nagao S., Wallace D.P., et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys. Kidney Int 63 (2003) 1983-1994
16. Yamaguchi T., Wallace D.P., Magenheimer B.S., et al. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem 279 (2004) 40419-40430
17. Belibi F.A., Reif G., Wallace D.P., et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int 66 (2004) 964-973
18. Yamaguchi T., Hempson S.J., Reif G.A., et al. Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells. J Am Soc Nephrol 17 (2006) 178-187
19. Banales J.M., Masyuk T.V., Gradilone S.A., et al. The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD). Hepatology 49 (2009) 160-174
20. Torres V.E., and Harris P.C. Mechanisms of disease: autosomal dominant and recessive polycystic kidney diseases. Nat Clin Pract Nephrol 2 (2006) 40-55
21. Kip S.N., Hunter L.W., Ren Q., et al. [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circ Res 96 (2005) 873-880
22. Gradilone S.A., Masyuk A.I., Splinter P., et al. Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion. Proc Natl Acad Sci U S A 104 (2007) 19138-19143
23. Kottgen M., Buchholz B., Garcia-Gonzalez M.A., et al. TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 182 (2008) 437-447
24. Watanabe H., Davis J.B., Smart D., et al. Activation of TRPV4 channels (hVRL-2/mTRP12) by phorbol derivatives. J Biol Chem 277 (2002) 13569-13577
25. Thorneloe K.S., Sulpizio A.C., Lin Z., et al. N-((1S)-1-{[4-((2S)-2-{[(2,4-dichlorophenyl)sulfonyl]amino}-3-hydroxypro pa noyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxam id e (GSK1016790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity: part I. J Pharmacol Exp Ther 326 (2008) 432-442
26. Watanabe H., Vriens J., Prenen J., et al. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424 (2003) 434-438
27. Vriens J., Owsianik G., Fisslthaler B., et al. Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res 97 (2005) 908-915
28. Muff M.A., Masyuk T.V., Stroope A.J., et al. Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of autosomal recessive polycystic kidney disease. Lab Invest 86 (2006) 940-950
29. Becker D., Blase C., Bereiter-Hahn J., et al. TRPV4 exhibits a functional role in cell-volume regulation. J Cell Sci 118 (2005) 2435-2440
30. Masyuk T.V., Huang B.Q., Masyuk A.I., et al. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease. Am J Pathol 165 (2004) 1719-1730
31. Masyuk A.I., Gradilone S.A., Banales J.M., et al. Cholangiocyte primary cilia are chemosensory organelles that detect biliary nucleotides via P2Y12 purinergic receptors. Am J Physiol Gastrointest Liver Physiol 295 (2008) G725-G734
32. Willette R.N., Bao W., Nerurkar S., et al. Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: part 2. J Pharmacol Exp Ther 326 (2008) 443-452
33. Leuenroth S.J., Okuhara D., Shotwell J.D., et al. Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci U S A 104 (2007) 4389-4394
34. Wang X., Harris P.C., Somlo S., et al. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrol Dial Transplant 24 (2009) 526-534
35. Gattone II V.H., Chen N.X., Sinders R.M., et al. Calcimimetic inhibits late-stage cyst growth in ADPKD. J Am Soc Nephrol 20 (2009) 1527-1532
36. Liedtke W., Choe Y., Marti-Renom M.A., et al. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor. Cell 103 (2000) 525-535
37. Strotmann R., Harteneck C., Nunnenmacher K., et al. OTRPC4, a nonselective cation channel that confers sensitivity to extracellular osmolarity. Nat Cell Biol 2 (2000) 695-702
38. Wissenbach U., Bodding M., Freichel M., et al. Trp12, a novel Trp related protein from kidney. FEBS Lett 485 (2000) 127-134
39. Liedtke W. TRPV4 plays an evolutionary conserved role in the transduction of osmotic and mechanical stimuli in live animals. J Physiol 567 (2005) 53-58
40. Harteneck C., and Reiter B. TRP channels activated by extracellular hypo-osmoticity in epithelia. Biochem Soc Trans 35 (2007) 91-95
41. Ramsey I.S., Delling M., and Clapham D.E. An introduction to TRP channels. Annu Rev Physiol 68 (2006) 619-647
42. Banales J.M., Masyuk T.V., Bogert P.S., et al. Hepatic cystogenesis is associated with abnormal expression and location of ion transporters and water channels in an animal model of autosomal recessive polycystic kidney disease. Am J Pathol 173 (2008) 1637-1646
43. D'Hoedt D., Owsianik G., Prenen J., et al. Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3. J Biol Chem 283 (2008) 6272-6280
44. Nichols M.T., Gidey E., Matzakos T., et al. Secretion of cytokines and growth factors into autosomal dominant polycystic kidney disease liver cyst fluid. Hepatology 40 (2004) 836-846
45. Masyuk T.V., Huang B.Q., Ward C.J., et al. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology 125 (2003) 1303-1310
46. Nagano J., Kitamura K., Hujer K.M., et al. Fibrocystin interacts with CAML, a protein involved in Ca2+ signaling. Biochem Biophys Res Commun 338 (2005) 880-889
47. Wang S., Zhang J., Nauli S.M., et al. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol Cell Biol 27 (2007) 3241-3252
48. Rohatgi R., Battini L., Kim P., et al. Mechanoregulation of intracellular Ca2+ in human autosomal recessive polycystic kidney disease cyst-lining renal epithelial cells. Am J Physiol Renal Physiol 294 (2008) F890-F899
49. Kim I., Fu Y., Hui K., et al. Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J Am Soc Nephrol 19 (2008) 455-468
50. Kim I., Li C., Liang D., et al. Polycystin-2 expression is regulated by a PC2-binding domain in the intracellular portion of fibrocystin. J Biol Chem 283 (2008) 31559-31566
51. Minagawa N., Ehrlich B.E., and Nathanson M.H. Calcium signaling in cholangiocytes. World J Gastroenterol 12 (2006) 3466-3470
52. Yamaguchi T., Pelling J.C., Ramaswamy N.T., et al. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int 57 (2000) 1460-1471
53. Guan K.L., Figueroa C., Brtva T.R., et al. Negative regulation of the serine/threonine kinase B-Raf by Akt. J Biol Chem 275 (2000) 27354-27359
54. Alessandri-Haber N., Dina O.A., Joseph E.K., et al. A transient receptor potential vanilloid 4-dependent mechanism of hyperalgesia is engaged by concerted action of inflammatory mediators. J Neurosci 26 (2006) 3864-3874
55. Cenac N., Altier C., Chapman K., et al. Transient receptor potential vanilloid-4 has a major role in visceral hypersensitivity symptoms. Gastroenterology 135 (2008) 937-946